Suppr超能文献

高影响力心脏病学期刊中已发表的系统评价的质量评估:重新审视证据金字塔

Quality Assessment of Published Systematic Reviews in High Impact Cardiology Journals: Revisiting the Evidence Pyramid.

作者信息

Abushouk Abdelrahman I, Yunusa Ismaeel, Elmehrath Ahmed O, Elmatboly Abdelmagid M, Fayek Shady Hany, Abdelfattah Omar M, Saad Anas, Isogai Toshiaki, Shekhar Shashank, Kalra Ankur, Reed Grant W, Puri Rishi, Kapadia Samir

机构信息

Department of Cardiovascular Medicine, Heart, Vascular & Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH, United States.

Harvard T.H Chan School of Public Health, Harvard University, Boston, MA, United States.

出版信息

Front Cardiovasc Med. 2021 Jun 9;8:671569. doi: 10.3389/fcvm.2021.671569. eCollection 2021.

Abstract

Systematic reviews are increasingly used as sources of evidence in clinical cardiology guidelines. In the present study, we aimed to assess the quality of published systematic reviews in high impact cardiology journals. We searched PubMed for systematic reviews published between 2010 and 2019 in five general cardiology journals with the highest impact factor (according to Clarivate Analytics 2019). We extracted data on eligibility criteria, methodological characteristics, bias assessments, and sources of funding. Further, we assessed the quality of retrieved reviews using the AMSTAR tool. A total of 352 systematic reviews were assessed. The AMSTAR quality score was low or critically low in 71% (95% CI: 65.7-75.4) of the assessed reviews. Sixty-four reviews (18.2%, 95% CI: 14.5-22.6) registered/published their protocol. Only 221 reviews (62.8%, 95% CI: 57.6-67.7) reported adherence to the EQUATOR checklists, 208 reviews (58.4%, 95% CI: 53.9-64.1) assessed the risk of bias in the included studies, and 177 reviews (52.3%, 95% CI: 45.1-55.5) assessed the risk of publication bias in their primary outcome analysis. The primary outcome was statistically significant in 274 (79.6%, 95% CI: 75.1-83.6) and had statistical heterogeneity in 167 (48.5%, 95% CI: 43.3-53.8) reviews. The use and sources of external funding was not disclosed in 87 reviews (24.7%, 95% CI: 20.5-29.5). Data analysis showed that the existence of publication bias was significantly associated with statistical heterogeneity of the primary outcome and that complex design, larger sample size, and higher AMSTAR quality score were associated with higher citation metrics. Our analysis uncovered widespread gaps in conducting and reporting systematic reviews in cardiology. These findings highlight the importance of rigorous editorial and peer review policies in systematic review publishing, as well as education of the investigators and clinicians on the synthesis and interpretation of evidence.

摘要

系统评价越来越多地被用作临床心脏病学指南的证据来源。在本研究中,我们旨在评估高影响力心脏病学期刊上已发表的系统评价的质量。我们在PubMed中检索了2010年至2019年期间在五本影响因子最高的普通心脏病学期刊上发表的系统评价(根据科睿唯安2019年数据)。我们提取了关于纳入标准、方法学特征、偏倚评估和资金来源的数据。此外,我们使用AMSTAR工具评估检索到的评价的质量。共评估了352篇系统评价。在71%(95%CI:65.7 - 75.4)的评估评价中,AMSTAR质量评分低或极低。64篇评价(18.2%,95%CI:14.5 - 22.6)登记/发表了其方案。只有221篇评价(62.8%,95%CI:57.6 - 67.7)报告遵循了EQUATOR清单,208篇评价(58.4%,95%CI:53.9 - 64.1)评估了纳入研究中的偏倚风险,177篇评价(52.3%,95%CI:45.1 - 55.5)在其主要结局分析中评估了发表偏倚风险。274篇评价(79.6%,95%CI:75.1 - 83.6)的主要结局具有统计学意义,167篇评价(48.5%,95%CI:43.3 - 53.8)存在统计学异质性。87篇评价(24.7%,95%CI:20.5 - 29.5)未披露外部资金的使用情况和来源。数据分析表明,发表偏倚的存在与主要结局的统计学异质性显著相关,复杂设计、更大样本量和更高的AMSTAR质量评分与更高的引用指标相关。我们的分析发现心脏病学系统评价在开展和报告方面存在广泛差距。这些发现凸显了系统评价发表中严格的编辑和同行评审政策的重要性,以及对研究者和临床医生进行证据综合与解读教育的重要性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验